Method of treating defective T-lymphocyte function with rutin or troxerutin in combination with .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid
US4888326A · kind A · utility
36Cited by
2References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 4, 1988 |
| Grant date | Dec 19, 1989 |
| Priority date | — |
| Expiry date | Mar 4, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition comprises one or more essential fatty acids, for example, .gamma.-linolenic acid or dihomo-.gamma.-linolenic acid, in conjunction with rutin, troxerutin or other bioflavonoid. The composition is useful in the treatment of inflammation or defective T-lymphocyte function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.